Page last updated: 2024-10-30

kynurenic acid and Muscular Dystrophy, Duchenne

kynurenic acid has been researched along with Muscular Dystrophy, Duchenne in 1 studies

Kynurenic Acid: A broad-spectrum excitatory amino acid antagonist used as a research tool.
kynurenic acid : A quinolinemonocarboxylic acid that is quinoline-2-carboxylic acid substituted by a hydroxy group at C-4.

Muscular Dystrophy, Duchenne: An X-linked recessive muscle disease caused by an inability to synthesize DYSTROPHIN, which is involved with maintaining the integrity of the sarcolemma. Muscle fibers undergo a process that features degeneration and regeneration. Clinical manifestations include proximal weakness in the first few years of life, pseudohypertrophy, cardiomyopathy (see MYOCARDIAL DISEASES), and an increased incidence of impaired mentation. Becker muscular dystrophy is a closely related condition featuring a later onset of disease (usually adolescence) and a slowly progressive course. (Adams et al., Principles of Neurology, 6th ed, p1415)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Copeland, EN1
Watson, CJF1
Whitley, KC1
Baranowski, BJ1
Kurgan, N1
MacNeil, AJ1
MacPherson, REK1
Fajardo, VA1
Allison, DJ1

Other Studies

1 other study available for kynurenic acid and Muscular Dystrophy, Duchenne

ArticleYear
Kynurenine metabolism is altered in mdx mice: a potential muscle to brain connection.
    Experimental physiology, 2022, Volume: 107, Issue:9

    Topics: Animals; Brain; Disease Models, Animal; Kynurenic Acid; Kynurenine; Mice; Mice, Inbred C57BL; Mice,

2022